← Open Payments lookup

HABIBATU SESAY: Open Payments

NPI 1043852023 · NORTH POTOMAC, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,727 in 74 payments from 13 companies in 2025. Trend: 2023 $1,261 · 2024 $1,351 · 2025 $1,727

Food & beverage: $1,723Education: $4
CompanyPaymentsAmount
ABBVIE INC.14$338
Teva Pharmaceuticals USA, Inc.7$285
Otsuka America Pharmaceutical, Inc.15$235
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$209
Neurocrine BioSciences, Inc.8$172
Lundbeck LLC8$164
Supernus Pharmaceuticals, Inc.3$133
Alkermes, Inc.3$51
Takeda Pharmaceuticals U.S.A., Inc.2$41
Axsome Therapeutics, Inc.2$36

Products named: VRAYLAR, REXULTI, UZEDY, CAPLYTA, INGREZZA, Qelbree, ABILIFY MAINTENA, ARISTADA.

Industry payments across MD — which companies pay providers there.